Design and rationale for a randomized, open-label, parallel clinical trial evaluating major adverse cardiovascular events (pharmacological treatment versus diet control) in patients with high-normal blood pressure: the PRINT-TAHA9 trial
The PRINT-TAHA9 trial was registered in October 2019 with the Iranian Registry of Clinical Trials (IRCT.ir) under the registration number IRCT20191002044961N1. https://irct.behdasht.gov.ir/trial/43092 .
Authors
- Mehrab Sayadi (ORCID: https://orcid.org/0000-0003-2575-790X)
- Iman Razeghian‐Jahromi (ORCID: https://orcid.org/0000-0001-8137-786X)
- Roham Borazjani (ORCID: https://orcid.org/0000-0001-5391-2490)
- Mahsa Ahadi (ORCID: https://orcid.org/0000-0002-0995-3102)
- Armin Attar (ORCID: https://orcid.org/0000-0002-4133-4870)
- Mohammad Javad Zibaeenezhad (ORCID: https://orcid.org/0000-0001-7157-6486)
- Nader Parsa (ORCID: https://orcid.org/0000-0001-9063-7512)
- Seyed Alireza Mirhosseini (ORCID: https://orcid.org/0009-0000-3920-8640)
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Trials
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1186/s13063-024-08420-2
- Citations
- 1
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Shiraz University of Medical Sciences
- Shiraz University